Indiana comptroller calls for SEC to delist Chinese companies
Comptroller Elise Nieshalla testifies before the Senate Elections Committee on Monday, Jan. 13, 2025. (Leslie Bonilla Muñiz/Indiana Capital Chronicle)
Indiana, alongside 20 other states, penned a letter last month urging the Securities and Exchange Commission to investigate delisting China-based companies on U.S. stock exchanges 'to protect American investors.'
Indiana Comptroller Elise Nieshalla and other state financial officers said there is a growing risk posed by the China-based companies due to Chinese Communist Party interference and widespread failures to meet U.S. transparency, accounting and auditing standards.
'As stewards of invested public funds, we have a responsibility to protect our beneficiaries from foreign entities to seek to exploit our capital markets while evading accountability,' Nieshalla said in a press release.
CONTACT US
The letter highlights the Chinese Communist Party's crackdown on independent due-diligence firms and points to findings by the Public Company Accounting Oversight Board that revealed auditing failures among Chinese companies. It also states that the CCP's systematic use of Variable Interest Entities — an organization that is controlled through contractual agreements rather than direct ownership — prevents U.S. investors from owning the company.
The state financial officers also direct the SEC to investigate potential violations of the Securities Exchange Act, including disclosure of controls and procedures, internal financial reporting mechanisms, falsified accounting records and manipulative or deceptive practices. They alleged that the CCP's efforts to suppress transparency exacerbated these issues.
'As state financial officers, part of our responsibility is to ensure that the American people's finances – and our American financial system – are protected from foreign actors who mean to do us harm,' the signatories said in the letter.
Indiana has recently purged Chinese companies from state investments.
In 2023, legislation was passed that required the Indiana Public Retirement System to divest from any entities that do military or intelligence work or are controlled by the Chinese government. Within a year, INPRS eliminated its $1.2 billion worth of investments in Chinese entities.
Delisting-Letter
SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
22 minutes ago
- Time Business News
Best Electrical Services on the Sunshine Coast — Niche Electrical Group
When you're looking for dependable electrical work on the Sunshine Coast, you need a team that's experienced, licensed, and focused on safety. At Niche Electrical Group, we provide high-quality electrical services across residential, commercial, and industrial sectors — with a reputation for prompt, efficient solutions that last. From urgent electrical faults to major installations, our electricians handle every job with precision and care. Our standout offering? Specialised industrial electrical maintenance that ensures your critical systems operate safely and efficiently year-round. Why Locals Choose Niche Electrical Group As a Sunshine Coast-based company, we take pride in delivering electrical services that meet the specific needs of our local community. Our fully insured and qualified team has experience across all types of projects — from home renovations to factory fit-outs — always with a strong focus on safety, compliance, and customer satisfaction. We use the latest tools and high-quality materials to guarantee reliable results. Whether you're upgrading your home's lighting or planning a long-term industrial electrical maintenance strategy, you can count on us to get it right the first time. Electrical Services for Every Environment Residential Electrical Ensure your home is powered safely and efficiently with our full range of residential services: Custom lighting design and installs Switchboard upgrades Safety switch and smoke alarm installation Home security systems and smart automation General fault finding and compliance checks Need help fast? We also offer quick-response emergency services and preventative maintenance. Commercial Electrical Businesses need electrical systems they can rely on. We offer tailored solutions for: Shop and office fit-outs Network and data cabling LED lighting upgrades Test and tag compliance Switches, power outlets, and more Our electricians work to your schedule, delivering projects on time and within budget. The Sunshine Coast's Industrial Electrical Maintenance Experts For industrial clients, we offer complete industrial electrical maintenance services to help keep operations running without disruption. Industrial environments require robust, expertly maintained systems — and our team delivers exactly that. What Does Industrial Electrical Maintenance Involve? It's the regular servicing, repair, and inspection of electrical systems in plants, warehouses, and production facilities. We work on: Switchboards and control panels High-voltage motors and drives PLCs and automation systems Industrial lighting and HVAC Power distribution setups Emergency systems (UPS, generators) Our trained electricians ensure all work complies with WHS regulations and Australian electrical standards. Why Preventive Maintenance Matters Avoid Downtime : Catch issues early before they cause system failures : Catch issues early before they cause system failures Extend Equipment Life : Keep components running longer : Keep components running longer Boost Safety : Prevent electrical hazards with regular checks : Prevent electrical hazards with regular checks Cut Energy Waste : Identify and fix inefficiencies : Identify and fix inefficiencies Stay Compliant: Meet all local safety and wiring codes Available 24/7 for Emergency Electrical Work Power failures and unexpected issues don't follow a 9-to-5 schedule. That's why Niche Electrical Group is available around the clock to handle emergency situations. Whether it's your home, business, or industrial site, we respond fast to get things running again. Local Electricians You Can Trust We're proud to be part of the Sunshine Coast community — known for our honest advice, professional workmanship, and dedication to quality. From once-off callouts to long-term maintenance plans, Niche Electrical Group is ready to be your go-to electrical partner. Explore our full range of services and discover why more locals are turning to us for reliable industrial electrical maintenance and beyond. TIME BUSINESS NEWS
Yahoo
22 minutes ago
- Yahoo
Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025
Emerging Biomarkers in the Clinical Development of Epilepsy Medicines and OV329 Program Highlights NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, will host an investor and media event on Thursday, June 12, 2025, on the topic of applying Biomarkers in Epilepsy, including their strategic use to demonstrate the pharmacodynamic activity of the Company's OV329 clinical development program. World-leading expert, Dr. Alexander Rotenberg will join company management to discuss the emerging use of a wide range of biomarkers for the study of anti-seizure medicines. The event will take place at Ovid's headquarters in New York's Hudson Yards from 9:30 to 10:30 am ET and will be webcast simultaneously. Sophisticated imaging and radiological tools are increasingly enabling medicines developers to leverage biomarkers earlier in clinical development to identify signals of biological target engagement and pharmacodynamic activity. Discussion will focus on how these tools drive evidence informed approaches in drug development and provide insight into potential clinical outcomes. Ovid management will describe the exploratory biomarkers in use to measure its next-generation GABA-aminotransferase (GABA-AT) inhibitor program, OV329, which is anticipated to have a topline readout in Q3 2025. Keynote speaker: Leading pediatric neurologist and epileptologist Alexander Rotenberg, M.D., Ph.D. Professor of Neurology at Boston Children's Hospital and Harvard Medical School, and Director of the Epilepsy Monitoring Unit at Boston Children's Hospital, and the Experimental Neurophysiology Core at F.M. Kirby Center of Neurobiology Unfortunately, nearly 40 percent of people living with epilepsy continue to experience seizures despite existing medicines. OV329 is a next-generation GABA-AT inhibitor, that was rationally designed to work differently from current medicines and may offer a novel approach for patients with treatment-resistant seizures. OV329 seeks to endogenously deliver optimal levels of GABA to reduce seizures and provide a preferable safety and tolerability profile relative to the first-generation, GABA-AT inhibitor, vigabatrin. OV329 is currently completing a Phase 1 study that is evaluating its effects on multiple pharmacodynamic biomarkers, safety, tolerability, and pharmacokinetics. Interested in attending or participating remotely: To register, please visit: Registration Link A live webcast of the presentation can be accessed through the Events & Presentations section of Ovid's website at About Ovid Therapeutics Ovid Therapeutics Inc. is a New York-based biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need. The Company is advancing a pipeline of novel, targeted small molecule candidates that modulate the intrinsic and extrinsic factors involved in neuronal hyperexcitability causative of multiple neurological and neuropsychiatric disorders. Ovid is developing: OV329, a next-generation GABA-aminotransferase inhibitor, as a potential therapy for treatment-resistant seizures and other undisclosed indications; OV350, OV4071 and others within a library of compounds that directly activate the KCC2 transporter, for multiple CNS disorders. For more information about these and other Ovid research programs, please visit Forward-Looking Statements This press release includes certain disclosures by Ovid that contain 'forward-looking statements' including, without limitation: statements regarding the expected timing of initiation, completion, and results and data of Ovid's clinical studies; the potential use and development of OV329, OV350, OV4071 and other compounds from Ovid's library of direct activators of KCC2; and other statements that are not historical fact. You can identify forward-looking statements because they contain words such as 'anticipates,' 'believes,' 'expects,' 'intends,' 'may,' 'plan,' 'potentially,' and 'will,' and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances). Forward-looking statements are based on Ovid's current expectations and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements, which are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, uncertainties inherent in the preclinical and clinical development and regulatory approval processes, risks related to Ovid's ability to achieve its financial objectives, the risk that Ovid may not be able to realize the intended benefits of its business strategy or unanticipated or greater than anticipated impacts or delays due to macroeconomic and geopolitical conditions. Additional risks that could cause actual results to differ materially from those in the forward-looking statements are set forth under the caption 'Risk Factors' in Ovid's most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission ('SEC'), and in subsequent and future filings Ovid makes with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and Ovid assumes no obligation to update any forward-looking statements contained herein, whether because of any new information, future events, changed circumstances or otherwise, except as otherwise required by law. Media and Investor Relations:Victoria Fort vfort@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Big central banks' forecasting lens gets fogged by US tariffs
By Naomi Rovnick LONDON (Reuters) -Unpredictable White House tariff rhetoric and its impact on currency markets, oil prices and the inflation outlook have put central banks across the world in a tight spot. The European Central Bank cut interest rates on Thursday and looks set to pause, Switzerland appears to be moving back towards negative rates, Japan's resolve to drop ultra-easy monetary policy is wobbling, and baffling U.S. data could keep the Federal Reserve in wait-and-see mode. Here's a look at where 10 developed-market central banks stand. 1/ SWITZERLAND The Swiss National Bank next meets on June 19, and traders see a one in three chance that it will pull rates back into negative territory from 0.25% currently after consumer prices fell for the first time in four years. The safe-haven Swiss franc has gained 10% against the dollar so far this year on geopolitical and market volatility. That's challenging Switzerland's export-heavy economy and cheapened imports, giving the SNB reasons to be wary about deflation. 2/ CANADA The Bank of Canada held rates at 2.75% on Wednesday and said another cut might be necessary if the economy weakened in the face of tariffs. The BoC has held rates for a second time in a row after an aggressive cutting cycle which shrunk rates by 225 basis points over nine months. Markets price in a roughly 85% chance of another quarter-point cut by September. 3/ NEW ZEALAND Money markets expect the Reserve Bank of New Zealand to hold steady on July 9 after a 25 bps rate cut to 3.25% in May to protect the China-focused economy. The RBNZ also warned that global trade uncertainties made future moves unclear. 4/ SWEDEN Sweden's central bank left its key rate unchanged at 2.25% in May but with on-again-off-again U.S. tariffs now having contributed to an economic contraction in the first quarter, the Riksbank has signaled more easing ahead. Its next rate decision is on June 18. 5/ EURO ZONE The ECB cut rates as expected on Thursday and kept all options on the table for its next meetings even as the case grows for a summer pause in its year-long easing cycle. It has lowered rates eight times in the last year, and markets price in one more rate cut by year-end. 6/ UNITED STATES The Fed, under consistent fire from President Donald Trump for resisting rate cuts, is expected to hold steady at its next June 18 meeting as tariff uncertainty makes wait-and-see its best option for now. With businesses spooked by Trump's aggressive trade talk, layoffs have increased, manufacturing orders have slumped and factory gate prices have surged, indicating stagflation risks that could moderate if the White House softens its stance. The Fed has held rates in the 4.25%-4.5% range since December, following 100 bps of cuts last year. Money markets price roughly 50 bps of further easing by year-end. 7/ BRITAIN The Bank of England, which has lowered borrowing costs slowly to accommodate bumpy inflation trends, cut rates by 25 bps to 4.25% last month and revealed an unexpected three-way split among its policymakers that signaled uncertainty ahead. Governor Andrew Bailey says the BoE was staying cautious amid unpredictable global trends. Traders expect no move in June and a 60% chance of a cut by August. 8/ AUSTRALIA Weak growth data and fears of Aussie commodities producers and miners taking big blows from a U.S.-China trade war means the Reserve Bank of Australia stands ready to ride to the rescue with rapid rate cuts. The RBA cut rates by 25 bps to 3.85% in May and traders see borrowing costs dropping to about 3% by year-end. 9/ NORWAY Norway's central bank has ditched plans to ease monetary policy as its oil-linked currency weakens amid global trade uncertainty, posing a fresh inflationary threat. The Norges Bank kept rates on hold at a 17-year high of 4.50% in May, and markets anticipate no change at the June 19 meeting. 10/ JAPAN The Bank of Japan, long expected to pursue rate hikes, faces a challenging mix of economic trends if tariffs hurt exports but inflation keeps rising. After the BoJ held borrowing costs steady at 0.5% in May, Governor Kazuo Ueda steadfastly refused to comment on the possible timing of the next increase. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
